SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-572621
Filing Date
2016-05-02
Accepted
2016-05-02 16:15:36
Documents
3
Period of Report
2016-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d176959d8k.htm 8-K 14590
2 EX-99.1 d176959dex991.htm EX-99.1 42921
3 GRAPHIC g176959ex99_1pg001.jpg GRAPHIC 16830
  Complete submission text file 0001193125-16-572621.txt   81988
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 161611814
SIC: 2834 Pharmaceutical Preparations